Showing results (81-90 of 128) with videos related to
Sort By:
Pageof 13
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 12, 2024
Inflammation-related biomarkers as predictors of pathological complete response in early-stage breast cancerOraianthi Fiste, Evangelos Mavrothalassitis, Alexandros Kokkalis, et al.Cancer Investigation|February 4, 2015
ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based ChemotherapyAristea Kalikaki, Alexandra Voutsina, Anastasios Koutsopoulos, et al.Oncology|November 14, 2007
A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumorsZacharenia Saridaki, Vasiliki Bozionelou, Nikolaos Kentepozidis, et al.Cancer Chemotherapy and Pharmacology|August 11, 2018
Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancerIppokratis Messaritakis, Maria Sfakianaki, Chara Papadaki, et al.Cancer Chemotherapy and Pharmacology|January 30, 2021
Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestaneMaria Spiliotaki, Galatea Kallergi, Christos Nikolaou, et al.Healthcare (Basel, Switzerland)|May 4, 2026
Determinants of Chemotherapy Convenience and Satisfaction: The Role of Symptom and Psychological Burden in Cancer Patients-A Cross-Sectional StudyEvangelos C Fradelos, Konstantinos Skampardonis, Pavlos Sarafis, et al.Lung Cancer (Amsterdam, Netherlands)|March 28, 2006
A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancerAthanasios G Pallis, Athina Agelidou, Pavlos Papakotoulas, et al.Oncology Research|June 3, 2026
Repurposing Artesunate to Combat Progression and Metastasis via Targeting Circulating Tumor CellsEvangelia Pantazaka, Dimitrios Papakonstantinou, Argyro Roumeliotou, et al.Therapeutic Advances in Medical Oncology|February 1, 2018
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancerGalatea Kallergi, Eleni-Kyriaki Vetsika, Despoina Aggouraki, et al.Cancers|January 8, 2023
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer PatientsArgyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara, et al.Pageof 13